Stallergenes Greer

Developing allergen immunotherapy (vaccine) for respiratory allergies

placeLondon, England, United Kingdom calendar_todayFounded 2013 groups115,499 employees language stallergenesgreer.com

Registered entities

Investor mix

2 investors on record.

Investor typeCountShare
Private equity150%
Other / undisclosed150%

Hiring activity

Hires periodically

5 roles tracked across 4 of the last 12 months

3 Apr 2026 · Senior Medical Advisor (H/F) · Antony

25 Mar 2026 · Alternant Marketing Pharmaceutique HF · Antony

5 Jan 2026 · Stage Marketing Pharmaceutique H/F · Antony

29 Nov 2025 · Chargé Assurance Qualité Produit & Distribution H/F · Antony

28 Oct 2025 · Responsable Équipe Analytique Cq Microbiologie CDD H/F · Antony

Based on job postings tracked across public sources.

Coming soon